REVOLVING CREDIT AGREEMENT dated as of November 22, 2016 among MYLAN N.V., as Borrower and The Guarantors party hereto and BANK OF AMERICA, N.A., as Administrative Agent and the Lenders and the Issuing Banks party hereto MERRILL LYNCH, PIERCE, FENNER...Revolving Credit Agreement • March 1st, 2017 • Mylan N.V. • Pharmaceutical preparations • New York
This REVOLVING CREDIT AGREEMENT (this “Agreement”) is dated as of November 22, 2016 among MYLAN N.V., a public limited liability company (naamloze vennootschap) incorporated and existing under the laws of the Netherlands, with its corporate seat (statutaire zetel) in Amsterdam, the Netherlands and registered with the Dutch chamber of commerce under number 61036137 (the “Borrower”), certain Affiliates and Subsidiaries of the Borrower from time to time party hereto as Guarantors, each Lender and Issuing Bank from time to time party hereto, and BANK OF AMERICA, N.A., as Administrative Agent.
TERM CREDIT AGREEMENT dated as of November 22, 2016 among MYLAN N.V., as Borrower and the Guarantors party hereto and GOLDMAN SACHS BANK USA, as Administrative Agent and the Lenders party hereto GOLDMAN SACHS BANK USA, MERRILL LYNCH, PIERCE, FENNER &...Term Credit Agreement • March 1st, 2017 • Mylan N.V. • Pharmaceutical preparations • New York
This TERM CREDIT AGREEMENT (this “Agreement”) is dated as of November 22, 2016 among MYLAN N.V., a public limited liability company (naamloze vennootschap) incorporated and existing under the laws of the Netherlands, with its corporate seat (statutaire zetel) in Amsterdam, the Netherlands and registered with the Dutch chamber of commerce under number 61036137 (the “Borrower”), certain Affiliates and Subsidiaries of the Borrower from time to time party hereto as Guarantors, each Lender from time to time party hereto, and GOLDMAN SACHS BANK USA, as Administrative Agent.
Mylan N.V. One-Time Special Five-Year Performance-Based Realizable Value Incentive Program Performance-Based Restricted Stock Unit Award AgreementPerformance-Based Restricted Stock Unit Award Agreement • March 1st, 2017 • Mylan N.V. • Pharmaceutical preparations • Pennsylvania
Mylan N.V. (the “Company”) hereby grants to [●] (the “Participant”), effective as of [●] (the “Grant Date”), the performance-based restricted stock unit award (the “Performance RSUs”) as set forth in this Award Agreement. The Performance RSUs are subject to the terms and conditions set forth in this Award Agreement and in the Company’s 2003 Long-Term Incentive Plan, as amended (the “Plan”). In the event of any inconsistency between the terms of this Award Agreement and the terms of the Plan, the terms of the Plan shall govern except to the extent specifically set forth herein. Capitalized terms used but not defined in this Award Agreement (including Exhibit A hereto) shall have the meanings ascribed to them in the Plan. Notwithstanding the foregoing, the Performance RSUs shall be subject to any term of any employment agreement between the Company (or any Subsidiary) and the Participant that specifically references this Award Agreement (but, for the avoidance of doubt, shall not be subj
AMENDMENT LETTERSek 25,000,000,000 Multicurrency Term and Revolving Credit Facilities Agreement • March 1st, 2017 • Mylan N.V. • Pharmaceutical preparations
Meda AB (publ) — SEK 25,000,000,000 Multicurrency Term and Revolving Credit Facilities Agreement dated 17 December 2014, as amended by way of an amendment letter dated 29 October 2015 and an amendment and waiver letter dated 30 August 2016 (the “Agreement”)
AMENDMENT AND WAIVER AGREEMENT dated 22 December 2016 RELATING TO THE SEK 2,000,000,000 LOAN AGREEMENT dated 17 September 2014 for MEDA AB (PUBL) as Borrower with AB SVENSK EXPORTKREDIT (PUBL) as LenderLoan Agreement • March 1st, 2017 • Mylan N.V. • Pharmaceutical preparations
GUARANTEE AGREEMENTGuarantee Agreement • March 1st, 2017 • Mylan N.V. • Pharmaceutical preparations
GUARANTEE AGREEMENT (this “Guarantee”), dated as of December 22, 2016, among Mylan N.V., a public limited liability company (naamloze vennootschap) organized and existing under the laws of the Netherlands (the “Guarantor”), Meda AB (publ) (the “Borrower”) and AB Svensk Exportkredit (publ) (the “Lender”).
